Neuberger Berman Group »

Adagio Therapeutics shares owned by Neuberger Berman Group

Quarter-by-quarter ownership of Adagio Therapeutics (IVVD) shares owned by Neuberger Berman Group from 13F filings

Historical chart of Neuberger Berman Group investment in Adagio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Adagio Therapeutics held by Neuberger Berman Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adagio Therapeutics by Neuberger Berman Group

Quarter filed Position value Share count Share price at filing
2025-03-31 $9.7k 16k 0.61
2024-12-31 $9.6k 22k 0.44

More positions owned by Neuberger Berman Group

Microsoft Corp Common (MSFT)
Nvidia Corp Common (NVDA)
Apple Common (AAPL)
Amazon Common (AMZN)
Jpmorgan Chase & Co Common (JPM)
Alphabet Inc Class A A Common (GOOGL)
Alphabet Inc-cl C Common (GOOG)
Meta Platforms Inc Class A A Common (META)
Home Depot Common (HD)
Oracle Corp Common (ORCL)
Eli Lilly & Co Common (LLY)
Broadcom Common (AVGO)
Ishares Core S&p Etf Trust Etf-e Etf (IVV)
T Mobile Us Common (TMUS)
Berkshire Hathaway Inc Class B B Common (BRK.B)

View all positions for Neuberger Berman Group

Top funds holding Adagio Therapeutics

Henderson Group
Point72 Asset Management
Maverick Capital
RA Capital Management
Mithril II GP
Driehaus Capital Management
M28 Capital Management
ADAR1 Capital Management
683 Capital Management
Vanguard Group
Redmile Group
Ikarian Capital
Eversept Partners
Millennium Management
Boothbay Fund Management

View all funds holding Adagio Therapeutics